Kevin Weinstein focuses on helping to launch new companies, new products and grow new markets. Kevin “grew up” through the Marketing and Sales functions and is focused on finding companies and solutions that have the opportunity to delight customers and break new ground.
Kevin is currently the CEO of Analyte Health, a pioneering company empowering consumers to live healthier lives by making health and diagnostic lab tests accessible, understandable and actionable. Previously Kevin was the Chief Growth Officer at Valence Health, where he oversaw the company’s significant growth in revenue through the company’s successful sale to Evolent Health (NYSE: EVH). Kevin was responsible for all aspects of sales, marketing and corporate development during his tenure at Valence.
Previously, Kevin started the marketing department at ZirMed, a leading revenue cycle management technology company for healthcare providers backed by Sequoia Capital. Previously Kevin was an early executive at Rise Health and started his healthcare career as Vice President of Marketing and Sales Operations at Allscripts, a leading provider of clinical software, connectivity, and information solutions for physicians. Prior to Allscripts, Kevin was a consultant with Mercer Management Consulting. Before working in the for-profit sector, Kevin was involved in electoral politics, where he held varied positions including finance director, press secretary and field organizer of major federal, state and local campaigns.
Kevin received his B.A. in English from Colgate University and an M.B.A. from Northwestern’s Kellogg School of Management.